Navigation Links
Diplomat's 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
Date:7/17/2008

SWARTZ CREEK, Mich., July 17 /PRNewswire/ -- Diplomat Specialty Pharmacy, the nation's largest independent specialty pharmacy, released today results of their Spring 2008 Patient Satisfaction Survey. The national survey was mailed to 1500 patients, randomly selected from its own database of approximately 7500 patients. Without any offer of incentive, 568 surveys were returned to Diplomat, representing a very impressive 38% response rate.

Survey Says ...

-- 99% of patients are "satisfied" with Diplomat services, including a substantial 89% who are "very satisfied."

-- 98% of patients feel Diplomat meets their expectations "Most of the time," including a significant 86% who replied "All of the time."

-- 99% of patients say, "yes" they would recommend Diplomat to their family, friends and co-workers looking for a pharmacy.

"35 years ago Diplomat Specialty Pharmacy was built on personalized care, one patient at a time," said Phil Hagerman, President and CEO of Diplomat. "It is rewarding to know that we are successful because we still put our patients first. I congratulate all Diplomat employees whose high-touch patient care approach has led to industry leading patient satisfaction levels."

Diplomat contracted with Jarman-Johnson Communications and Gartner & Associates LLC to assist with survey analysis. The sampling error associated with a completed sample of 568 ranges from 0.8% to 4.1% at the 95% confidence level.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn's and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company also s
'/>"/>

SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies with REOLYSIN(R)
2. CV Therapeutics Receives European Marketing Authorization for Ranolazine for the Treatment of Patients With Chronic Angina
3. Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
4. Patients Who Bring Health Information from the Internet Get More Time with Doctor
5. National ePrescribing Patient Safety Initiative Supports Senates Call for Physicians to Adopt Electronic Prescribing, Improving Patient Safety
6. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
7. Superior Patient Clinical Outcomes Confirms DaVitas Leadership Position on Quality Dialysis Care
8. Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)
9. Number of Patients Treated with an Antibiotic for MRSA Within U.S. Acute Care Hospitals Increased 8 Percent from 2006 to 2007
10. New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients
11. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...care employment grew by 29,000 jobs in October, a...nt growth during the U.S. recession. However, clin... health systems are coming closer to having to act...istrators. , (Vocus) Nove...growing in October despite the shedding of jobs in...
(Date:11/24/2009)...ewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),...mercializingnovelpainmanagementtherapies,announced...Officer,isscheduledtopresentatthe21stAnnualPiperJa...atTheNewYorkPalaceHotelinNewYork,NewYork. ,, Mr...willbeavailabletorespondtoquestionsduringthepresen...
(Date:11/24/2009)...recently approved the Promega PowerPlex 16 HS Syst...erating DNA records for the National DNA Index Sys...RWEB) -- The FBI recently approved the Promega Po... participating in, or generating DNA records for, ...ly contains more than seven million profiles and h...
(Date:11/24/2009)...re-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),t...nouncedthatithassubmittedaMAAtotheEuropeanMedicine...lacementtherapyindevelopment,forthetreatmentofType...nforvelaglucerasealfathathasbeensubmitted,withprev... Basedonaglobalsupplyshortageofthecurrentlyapprove...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
... Wis. - Acknowledging that a return to profitabil...lthcare reported an annual net loss of $258.5 mil...006 that saw several executives resigned in the wa...ch included a goodwill impairment, trade name impa..., or $6.85 per share, compares to a net loss of $2...
...s. - State Senator Robert Cowles admitted his c...he worst news about the state of Wisconsin,s infor...ut in anticipation of the Legislative Audit Burea...colleague and a software executive, isn`t sure the...on is that the audit on state IT projects should b...
...rted this column just over four years ago, I had n...ar. My interest in writing a column was to share w...unity information that I thought would help them w...l awareness about life science in the Midwest. , ...ed that I couldn,t afford the kind of market resea...
Other Biology Technology:Merge Healthcare suffers $258M loss in `06 2Is the worst over for state technology failures? 2A Midwest life-science odyssey comes full circle 2A Midwest life-science odyssey comes full circle 3A Midwest life-science odyssey comes full circle 4A Midwest life-science odyssey comes full circle 5A Midwest life-science odyssey comes full circle 6A Midwest life-science odyssey comes full circle 7A Midwest life-science odyssey comes full circle 8
(Date:11/23/2009)...iated strain of the deadly superbug MRSAan infecti...ioticsposes a far greater health threat than previ...according to a study in the December issue of Eme... easily picked up in fitness centers, schools, and... burden of MRSA within hospitals, the report found...
(Date:11/23/2009)...ests that a common oral bacterium may exacerbate a...et al, "Unique Lipids from a Common Human Bacteriu... Enhancing Autoimmunity," appears in the December ... , Multiple sclerosis (MS), a disease where the ...ffects nearly 1 in 700 people in the United States...
(Date:11/23/2009)...University of Alabama at Birmingham (UAB) research...ng medical conditions (co-morbidity) do not explai...ericans compared to Caucasians who also have colon... Cancer , a journal of the American Cancer Society...co-morbidity are independent predictors of poor su...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 1Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 2Nepali Home Minister Commends Narconon International for Saving Lives 56495 1Nepali Home Minister Commends Narconon International for Saving Lives 56495 2The Dr Oz Show Names Core Team Oz 56493 1The Dr Oz Show Names Core Team Oz 56493 2The Dr Oz Show Names Core Team Oz 56493 3The Dr Oz Show Names Core Team Oz 56493 4
...the growth and development of plants, but what eff...aper by Nathalie Hoang et al., published in PLoS ...ining cryptochromes in flies, mice, and humans. In...which absorb and process blue light for functions ... stem expansion. Cryptochromes are present in huma...
...--In a breakthrough scientific study published tod...Sciences , scientists at the Burnham Institute for... development may be linked to Autism. The study de...factor 2C (MEF2C) protein in neural stem cells had...viors similar to those seen in humans with a form ...
...move that promises to change the economics of biod...ity have unveiled a set of techniques for cleanly ...ls that fetch a profit. , The latest research is ...ring . The new paper and others published earlier ... allows E. coli and other enteric bacteria to co...
Other Biology News:A mammalian clock protein responds directly to light 2Researchers link early stem cell mutation to autism 2Research yields pricey chemicals from biodiesel waste 2Research yields pricey chemicals from biodiesel waste 3
EasySep Mouse Combo Starter, Kit from StemCell Technologies, Inc.
...purified RNA samples., , This product has been...mples that have been pre-purified using traditiona...lica, oligo dT etc or other kits. , Our StabMRT ...stabilization of nanogram to milligram quantities ...
pORF-eSEAP from InvivoGen
Columbus from Tecan
Biology Products: